Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: A randomized, double-blind, cross-over trial

• Main Authors: Pan A., Sun J., Chen Y., Ye X., Li H., Yu Z., Wang Y., Gu W., Zhang X., Chen X., Wendy D.-W., Liu Y., Lin X.
• Other Authors: LIFE SCIENCES INSTITUTE
• Format: Article
• Published: 2019
• Subjects: enterodiol; enterolactone; flax essence; glucose; hemoglobin A1c; insulin; isoflavone derivative; lignan; lipid; placebo; adult; aged; article; China; clinical trial; controlled clinical trial; controlled study; crossover procedure; diarrhea; double blind procedure; drug bioavailability; drug efficacy; drug excretion; female; flatulence; glycemic control; human; hypercholesterolemia; insulin resistance; insulin sensitivity; linseed; lipid blood level; major clinical study; male; nausea; non insulin dependent diabetes mellitus; randomized controlled trial; treatment duration; chemistry; diet therapy; flax; middle aged; treatment outcome; Animalia; Aged; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Flax; Humans; Lignans; Male; Middle Aged; Placebos; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/161861
• Institution: National University of Singapore

10.1371/journal.pone.0001148